A Sydney-based study of 69 young people seeking mental health care found almost a quarter showed disrupted body clocks that showed signs that looked like jet lag, despite not having traveled across time zones. The […]
It’s common knowledge that obesity is a global epidemic, particularly in industrialized countries, and that it is a major cause of disease and poor overall health. However, there has been a tug-of-war in the debate […]
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors on the risk for gastroesophageal reflux disease (GERD) and its complications […]
In a new mouse study, researchers have used optical coherence tomography (OCT) to uncover new insights into how the fallopian tube transports preimplantation embryos toward the uterus for pregnancy. These findings help lay the foundation […]
The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review led by researchers at Oregon Health & Science University.This […]
New survey data from the Orlando Health Spine Center reveals a significant difference among Americans on how to manage neck and back pain. Respondents were split between relying on rest and reduced activity (44%), turning […]
A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.This article was […]
Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder (BD).This article was originally published on MedicalXpress.com
A population-based study led by the University of Turku, Finland, investigated factors associated with the prevalence of antibiotic resistance. In addition to antibiotic use, diet, gender, living environment, income level and certain gut bacteria were […]
Following priority review, the U.S. Food and Drug Administration approved Bayer’s Kerendia (finerenone) for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca